Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.057 AUD | +1.79% | -16.18% | -41.24% |
04-05 | Biotron Meets Primary Objectives of Phase Two HIV Trial; Shares Surge 25% | MT |
02-26 | Biotron Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Sales 2022 | 1.56M 1.01M 1.39M | Sales 2023 | 1.43M 927K 1.28M | Capitalization | 23.45M 15.19M 20.91M |
---|---|---|---|---|---|
Net income 2022 | -2M -1.3M -1.78M | Net income 2023 | -3M -1.94M -2.68M | EV / Sales 2022 | 26.4 x |
Net cash position 2022 | 1.66M 1.08M 1.48M | Net cash position 2023 | 3.94M 2.55M 3.51M | EV / Sales 2023 | 13.6 x |
P/E ratio 2022 |
-15.4
x | P/E ratio 2023 |
-6.11
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 80.28% |
1 day | +1.79% | ||
1 week | -16.18% | ||
Current month | -29.63% | ||
1 month | -29.63% | ||
3 months | -45.71% | ||
6 months | -32.94% | ||
Current year | -41.24% |
Managers | Title | Age | Since |
---|---|---|---|
Michelle Miller
CEO | Chief Executive Officer | - | 02-06-20 |
Stephen Becker
CTO | Chief Tech/Sci/R&D Officer | - | 20-07-16 |
Corporate Secretary | 67 | 99-02-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Thomas
BRD | Director/Board Member | 79 | 12-03-06 |
Michael Hoy
CHM | Chairman | 75 | 00-02-06 |
Michelle Miller
CEO | Chief Executive Officer | - | 02-06-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 0.057 | +1.79% | 498 464 |
24-04-29 | 0.056 | -8.20% | 3,308,478 |
24-04-26 | 0.061 | -10.29% | 6,837,962 |
24-04-24 | 0.068 | -1.45% | 828,126 |
24-04-23 | 0.069 | +1.47% | 328,410 |
Delayed Quote Australian S.E., April 30, 2024 at 02:10 am
More quotes1st Jan change | Capi. | |
---|---|---|
-41.24% | 33.14M | |
-3.46% | 102B | |
+1.41% | 96.29B | |
+2.13% | 22.18B | |
-15.84% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.65% | 16.36B | |
+4.39% | 13.97B | |
+31.35% | 12.17B |
- Stock Market
- Equities
- BIT Stock